Prevention and Management of HBV Infection in Patients with Chronic Kidney Disease Requiring Renal Transplantation
Current Hepatology Reports, ISSN: 2195-9595, Vol: 17, Issue: 4, Page: 485-491
2018
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Purpose of the Review: This review addresses clinical challenges of hepatitis B virus (HBV) infection in patients with chronic kidney disease and renal transplant recipients. Recent Findings: Prophylactic antiviral therapy with nucleos(t)ide analogues is key to prevent HBV reactivation in renal transplant recipients. In addition, attaining adequate immunity following vaccination against HBV may permit transplantation of renal grafts from donors with evidence of prior HBV infection. The role of nucleos(t)ide analogues for treatment of recurrent or de novo HBV infection in renal transplant recipients is well established and preliminary experience demonstrate significant reductions in the median time in the renal transplant waiting list by transplanting HBsAg-positive renal grafts into HBsAg-positive recipients, without sacrificing graft or patient survival with the use of these agents. Summary: Availability of potent nucleos(t)ide analogues results in improved outcomes following renal transplantation in patients with chronic HBV infection by avoiding recurrent or de novo infection.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85195575447&origin=inward; http://dx.doi.org/10.1007/s11901-018-0438-2; http://link.springer.com/10.1007/s11901-018-0438-2; http://link.springer.com/content/pdf/10.1007/s11901-018-0438-2.pdf; http://link.springer.com/article/10.1007/s11901-018-0438-2/fulltext.html; https://dx.doi.org/10.1007/s11901-018-0438-2; https://link.springer.com/article/10.1007/s11901-018-0438-2
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know